CardioPathy panel. versie V4 (167 genen) Centrum voor Medische Genetica Gent
|
|
- Sabina Bradley
- 5 years ago
- Views:
Transcription
1 CardioPathy panel versie V4 (167 genen) Centrum voor Medische Genetica Gent Gene OMIM gene ID ABCC Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance pattern Atrial fibrillation, familial, 12, (3), ; Cardiomyopathy, dilated, 1O, (3); Hypertrichotic osteochondrodysplasia, (3), ACADVL VLCAD deficiency, (3), Autosomal ACTA Aortic aneurysm, familial thoracic 6, (3), ; Moyamoya disease 5, (3); Multisystemic smooth muscle dysfunction syndrome, (3), ACTC ACTN Atrial septal defect 5, (3), ; Cardiomyopathy, dilated, 1R, (3), ; Cardiomyopathy, hypertrophic, 11, (3), ; Left ventricular noncompaction 4, (3), Cardiomyopathy, dilated, 1AA, with or without LVNC, (3), ; Cardiomyopathy, hypertrophic, 23, with or without LVNC, (3), AGL Glycogen storage disease IIIa, (3), Autosomal ; Glycogen storage disease IIIb, (3), Autosomal AKAP {Cardiac conduction defect, susceptibility to}, (3), Autosomal AKAP ?Long QT syndrome-11, (3), ALG {Long QT syndrome, acquired, reduced susceptibility to}, (3), ANK Cardiac arrhythmia, ankyrin-b-related, (3), ; Long QT syndrome 4, (3), ANKRD No OMIM phenotype ATP5E ?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3, (3) BAG Cardiomyopathy, dilated, 1HH, (3), ; Myopathy, myofibrillar, 6, (3), BRAF Adenocarcinoma of lung, somatic, (3); Cardiofaciocutaneous syndrome, (3), ; Colorectal cancer, somatic (3); LEOPARD syndrome 3, (3), ; Melanoma, malignant, somatic (3); Nonsmall cell lung cancer, somatic (3); Noonan syndrome 7, (3), CACNA1C Brugada syndrome 3, (3); Timothy syndrome, (3), CACNA2D No OMIM phenotype 1/12
2 CACNB Brugada syndrome 4, (3) CALM Long QT syndrome 14, (3), ; Ventricular tachycardia, catecholaminergic polymorphic, 4, (3), Autosomal CALM Long QT syndrome 15, (3), CALR ?Cardiomyopathy, hypertrophic, 19, (3), CASQ Ventricular tachycardia, catecholaminergic polymorphic, 2, (3), Autosomal CAV CBL Cardiomyopathy, familial hypertrophic, (3), ; Creatine phosphokinase, elevated serum, (3), Autosomal ; Long QT syndrome 9, (3), ; Muscular dystrophy, limb-girdle, type IC, (3), Autosomal, ; Myopathy, distal, Tateyama type, (3), ; Rippling muscle disease, (3), Autosomal?Juvenile myelomonocytic leukemia, (3),, Somatic mutation; Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia, (3), CFC Heterotaxy, visceral, 2, autosomal, (3), CITED Atrial septal defect 8, (3), ; Ventricular septal defect 2, (3), COA CRELD CRYAB ?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3, (3), Autosomal Atrioventricular septal defect, partial, with heterotaxy syndrome, (3), ; {Atrioventricular septal defect, susceptibility to, 2}, (3), Cardiomyopathy, dilated, 1II, (3), ; Cataract 16, multiple types, (3), Autosomal, ; Myopathy, myofibrillar, 2, (3), ; Myopathy, myofibrillar, fatal infantile hypertonic, alpha-b crystallin-related, (3), Autosomal CSRP ?Cardiomyopathy, dilated, 1M, (3); Cardiomyopathy, hypertrophic, 12, (3), CTF No OMIM phenotype CTNNA Macular dystrophy, patterned, 2, (3), CTNNA Arrhythmogenic right ventricular dysplasia, familial, 13, (3), DCHS Mitral valve prolapse 2, (3), ; Van Maldergem syndrome 1, (3), Autosomal 2/12
3 DES Cardiomyopathy, dilated, 1I, (3);?Muscular dystrophy, limb-girdle, type 2R, (3), Autosomal ; Myopathy, myofibrillar, 1, (3), Autosomal, ; Scapuloperoneal syndrome, neurogenic, Kaeser type, (3), DMD Becker muscular dystrophy, (3), X-linked ; Cardiomyopathy, dilated, 3B, (3), X-linked; Duchenne muscular dystrophy, (3), X-linked DMPK Myotonic dystrophy 1, (3), DNM1L Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1, (3), Autosomal, DOLK DPP Congenital disorder of glycosylation, type Im, (3), Autosomal Mental retardation, autosomal 33, (3); {Ventricular fibrillation, paroxysmal familial, 2}, (3), DSC DSG DSP DTNA ELN EMD EYA FBN Arrhythmogenic right ventricular dysplasia 11, (3), Autosomal, ; Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair, (3), Autosomal, Arrhythmogenic right ventricular dysplasia 10, (3), Autosomal ; Cardiomyopathy, dilated, 1BB, (3) Arrhythmogenic right ventricular dysplasia 8, (3), Autosomal ; Cardiomyopathy, dilated, with woolly hair and keratoderma, (3), Autosomal ; Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis, (3), ; Epidermolysis bullosa, lethal acantholytic, (3), Autosomal ; Keratosis palmoplantaris striata II, (3); Skin fragilitywoolly hair syndrome, (3), Autosomal Left ventricular noncompaction 1, with or without congenital heart defects, (3), Cutis laxa, autosomal, (3), ; Supravalvar aortic stenosis, (3), Emery-Dreifuss muscular dystrophy 1, X-linked, (3), X-linked Cardiomyopathy, dilated, 1J, (3); Deafness, autosomal 10, (3), Acromicric dysplasia, (3), ; Ectopia lentis, familial, (3), ; Geleophysic dysplasia 2, (3), ; MASS syndrome, (3); Marfan lipodystrophy syndrome, (3), ; Marfan syndrome, (3), ; Stiff skin syndrome, (3), ; Weill-Marchesani syndrome 2,, (3), 3/12
4 FBXO No OMIM phenotype FHL Emery-Dreifuss muscular dystrophy 6, X-linked, (3), X-linked ; Myopathy, X-linked, with postural muscle atrophy, (3), X-linked ; Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, (3), X-linked ; Reducing body myopathy, X-linked 1b, with late childhood or adult onset, (3), X- linked; Scapuloperoneal myopathy, X-linked, (3), X- linked FHL No OMIM phenotype FKRP Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, (3), Autosomal ; Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, (3), Autosomal ; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, (3), Autosomal FKTN Cardiomyopathy, dilated, 1X, (3), Autosomal ; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, (3), Autosomal ; Muscular dystrophydystroglycanopathy (congenital without mental retardation), type B, 4, (3), Autosomal ; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, (3), Autosomal FOXRED Leigh syndrome due to mitochondrial complex I deficiency, (3), Autosomal, Mitochondrial; Mitochondrial complex I deficiency, (3), Autosomal, X-linked, Mitochondrial FXN Friedreich ataxia, (3), Autosomal ; Friedreich ataxia with retained reflexes, (3), Autosomal GAA Glycogen storage disease II, (3), Autosomal GATA Atrial septal defect 2, (3), ; Atrioventricular septal defect 4, (3), ;?Testicular anomalies with or without congenital heart disease, (3), Autosomal ; Tetralogy of Fallot, (3), ; Ventricular septal defect 1, (3), GATA No OMIM phenotype GATA Atrial septal defect 9, (3), ; Atrioventricular septal defect 5, (3), ; Pancreatic agenesis and congenital heart defects, (3), ; Persistent truncus arteriosus, (3); Tetralogy of Fallot, (3), Autosomal GATAD ?Cardiomyopathy, dilated, 2B, (3), Autosomal 4/12
5 GDF GJA GJA GLA GLB Double-outlet right ventricle, (3); Right atrial isomerism, (3), Autosomal ; Tetralogy of Fallot, (3), Autosomal ; Transposition of great arteries, dextro-looped 3, (3), Atrioventricular septal defect 3, (3), ; Craniometaphyseal dysplasia, autosomal, (3), Autosomal ; Erythrokeratodermia variabilis et progressiva 3, (3); Hypoplastic left heart syndrome 1, (3), Autosomal ; Oculodentodigital dysplasia, (3), ; Oculodentodigital dysplasia, autosomal, (3), Autosomal ; Palmoplantar keratoderma with congenital alopecia, (3), ; Syndactyly, type III, (3), Autosomal Atrial fibrillation, familial, 11, (3), ; Atrial standstill, digenic (GJA5/SCN5A), (3), Fabry disease, (3), X-linked; Fabry disease, cardiac variant, (3), X-linked GM1-gangliosidosis, type I, (3), Autosomal ; GM1- gangliosidosis, type II, (3), Autosomal ; GM1- gangliosidosis, type III, (3), Autosomal ; Mucopolysaccharidosis type IVB (Morquio), (3), Autosomal GPD1L Brugada syndrome 2, (3) GUSB Mucopolysaccharidosis VII, (3), Autosomal HAND1 No OMIM gene No OMIM phenotype HCN Brugada syndrome 8, (3); Sick sinus syndrome 2, (3), HFE HRAS {Alzheimer disease, susceptibility to}, (3), ; Hemochromatosis, (3), Autosomal ; {Microvascular complications of diabetes 7}, (3); {Porphyria cutanea tarda, susceptibility to}, (3), Autosomal, ; {Porphyria variegata, susceptibility to}, (3), ; [Transferrin serum level QTL2], (3) {Bladder cancer, somatic}, (3); Congenital myopathy with excess of muscle spindles, (3),, Isolated cases; Costello syndrome, (3),, Isolated cases; {Nevus sebaceous or woolly hair nevus, somatic}, (3); Schimmelpenning- Feuerstein-Mims syndrome, somatic mosaic, (3); {Spitz nevus or nevus spilus, somatic}, (3); {Thyroid carcinoma, follicular, somatic}, (3) ILK No OMIM phenotype 5/12
6 JAG Alagille syndrome 1, (3), ;?Deafness, congenital heart defects, and posterior embryotoxon (3); Tetralogy of Fallot, (3), JPH Cardiomyopathy, hypertrophic, 17, (3), JUP Arrhythmogenic right ventricular dysplasia 12, (3), Autosomal ; Naxos disease, (3), Autosomal KCNA Atrial fibrillation, familial, 7, (3), KCND Brugada syndrome 9, (3), ; Spinocerebellar ataxia 19, (3), KCNE Jervell and Lange-Nielsen syndrome 2, (3), Autosomal ; Long QT syndrome 5, (3), KCNE Atrial fibrillation, familial, 4, (3); Long QT syndrome 6, (3), KCNE Brugada syndrome 6, (3) KCNE No OMIM phenotype KCNH Long QT syndrome 2, (3), ; {Long QT syndrome 2, acquired, susceptibility to}, (3), ; Short QT syndrome 1, (3) KCNJ Andersen syndrome, (3), ; Atrial fibrillation, familial, 9, (3), ; Short QT syndrome 3, (3) KCNJ Hyperaldosteronism, familial, type III, (3), ; Long QT syndrome 13, (3), KCNJ No OMIM phenotype KCNQ Atrial fibrillation, familial, 3, (3), ; Jervell and Lange-Nielsen syndrome, (3), Autosomal ; Long QT syndrome 1, (3), ; {Long QT syndrome 1, acquired, susceptibility to}, (3), ; Short QT syndrome 2, (3), KRAS Bladder cancer, somatic, (3); Breast cancer, somatic, (3); Cardiofaciocutaneous syndrome 2, (3); Gastric cancer, somatic, (3); Leukemia, acute myeloid, (3), ; Lung cancer, somatic, (3); Noonan syndrome 3, (3); Pancreatic carcinoma, somatic, (3); RAS-associated autoimmune leukoproliferative disorder, (3), ; Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, (3) LAMA Cardiomyopathy, dilated, 1JJ, (3), LAMP Danon disease, (3), X-linked 6/12
7 LDB Cardiomyopathy, dilated, 1C, with or without LVNC, (3), ; Cardiomyopathy, hypertrophic, 24, (3), ; Left ventricular noncompaction 3, (3), ; Myopathy, myofibrillar, 4, (3), Autosomal LMNA Cardiomyopathy, dilated, 1A, (3), ; Charcot- Marie-Tooth disease, type 2B1, (3), Autosomal ; Emery- Dreifuss muscular dystrophy 2, AD, (3), ; Emery-Dreifuss muscular dystrophy 3, AR, (3), Autosomal ; Heart-hand syndrome, Slovenian type, (3), Autosomal ; Hutchinson-Gilford progeria, (3), Autosomal, ; Lipodystrophy, familial partial, type 2, (3), ; Malouf syndrome, (3), Autosomal ; Mandibuloacral dysplasia, (3), Autosomal ; Muscular dystrophy, congenital, (3), ; Muscular dystrophy, limb-girdle, type 1B, (3), Autosomal ; Restrictive dermopathy, lethal, (3), Autosomal MAP2K Cardiofaciocutaneous syndrome 3, (3) MAP2K Cardiofaciocutaneous syndrome 4, (3) MED13L Mental retardation and distinctive facial features with or without cardiac defects, (3), ; Transposition of the great arteries, dextro-looped 1, (3), MIB Left ventricular noncompaction 7, (3), MRPL Combined oxidative phosphorylation deficiency 9, (3), Autosomal MYBPC Cardiomyopathy, dilated, 1MM, (3), ; Cardiomyopathy, hypertrophic, 4, (3), ; Left ventricular noncompaction 10, (3), MYH MYH Atrial septal defect 3, (3); Cardiomyopathy, dilated, 1EE, (3); Cardiomyopathy, hypertrophic, 14, (3), ; {Sick sinus syndrome 3}, (3) Cardiomyopathy, dilated, 1S, (3), ; Cardiomyopathy, hypertrophic, 1, (3), ; Laing distal myopathy, (3), ; Left ventricular noncompaction 5, (3), ; Myopathy, myosin storage, autosomal, (3), ; Myopathy, myosin storage, autosomal, (3), Autosomal ; Scapuloperoneal syndrome, myopathic type, (3), MYL Cardiomyopathy, hypertrophic, 10, (3), MYL Cardiomyopathy, hypertrophic, 8, (3), 7/12
8 MYLK Cardiomyopathy, hypertrophic, 1, digenic, (3), Autosomal MYOM No OMIM phenotype MYOZ No OMIM phenotype MYOZ Cardiomyopathy, hypertrophic, 16, (3), MYPN Cardiomyopathy, dilated, 1KK, (3), ; Cardiomyopathy, familial restrictive, 4, (3), ; Cardiomyopathy, hypertrophic, 22, (3), ; Nemaline myopathy 11, autosomal, (3), Autosomal NEBL No OMIM phenotype NEXN Cardiomyopathy, dilated, 1CC, (3), ; Cardiomyopathy, hypertrophic, 20, (3), NKX Atrial septal defect 7, with or without AV conduction defects, (3), ; Conotruncal heart malformations, variable, (3); Hypoplastic left heart syndrome 2, (3), ; Hypothyroidism, congenital nongoitrous, 5, (3), Autosomal ; Tetralogy of Fallot, (3), ; Ventricular septal defect 3, (3), NKX Conotruncal heart malformations, (3); Persistent truncus arteriosus, (3) NOS1AP No OMIM phenotype NPPA Atrial fibrillation, familial, 6, (3), ; Atrial standstill 2, (3), Autosomal NRAS Colorectal cancer, somatic, (3); Epidermal nevus, somatic, (3); Melanocytic nevus syndrome, congenital, somatic, (3); Neurocutaneous melanosis, somatic, (3); Noonan syndrome 6, (3), ;?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, (3); Thyroid carcinoma, follicular, somatic, (3) PDLIM No OMIM phenotype PKP Arrhythmogenic right ventricular dysplasia 9, (3), Autosomal PLN Cardiomyopathy, dilated, 1P, (3); Cardiomyopathy, hypertrophic, 18, (3), PRKAG Cardiomyopathy, hypertrophic 6, (3), ; Glycogen storage disease of heart, lethal congenital, (3), ; Wolff-Parkinson-White syndrome, (3),? 8/12
9 PSEN PSEN PTPN Acne inversa, familial, 3, (3), ; Alzheimer disease, type 3, (3), ; Alzheimer disease, type 3, with spastic paraparesis and apraxia, (3), ; Alzheimer disease, type 3, with spastic paraparesis and unusual plaques, (3), ; Cardiomyopathy, dilated, 1U, (3), ; Dementia, frontotemporal, (3), ; Pick disease, (3),, Isolated cases Alzheimer disease-4, (3), ; Cardiomyopathy, dilated, 1V, (3), LEOPARD syndrome 1, (3), ; Leukemia, juvenile myelomonocytic, somatic, (3); Metachondromatosis, (3), ; Noonan syndrome 1, (3), RAF Cardiomyopathy, dilated, 1NN, (3), ; LEOPARD syndrome 2, (3); Noonan syndrome 5, (3) RANGRF No OMIM phenotype RBM Cardiomyopathy, dilated, 1DD, (3), RYR Arrhythmogenic right ventricular dysplasia 2, (3), Autosomal ; Ventricular tachycardia, catecholaminergic polymorphic, 1, (3), SCN1B Atrial fibrillation, familial, 13, (3), ; Brugada syndrome 5, (3); Cardiac conduction defect, nonspecific, (3); Epilepsy, generalized, with febrile seizures plus, type 1, (3), ; Epileptic encephalopathy, early infantile, 52, (3), Autosomal SCN2B Atrial fibrillation, familial, 14, (3), SCN3B Atrial fibrillation, familial, 16, (3), ; Brugada syndrome 7, (3), SCN4B Atrial fibrillation, familial, 17, (3), ; Long QT syndrome-10, (3), SCN5A Atrial fibrillation, familial, 10, (3), ; Brugada syndrome 1, (3), ; Cardiomyopathy, dilated, 1E, (3), ; Heart block, nonprogressive, (3), ; Heart block, progressive, type IA, (3), ; Long QT syndrome-3, (3), Autosomal ; Sick sinus syndrome 1, (3), Autosomal ; {Sudden infant death syndrome, susceptibility to}, (3), Autosomal ; Ventricular fibrillation, familial, 1, (3) SCO Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1, (3), Autosomal ; Myopia 6, (3), 9/12
10 SDHA Cardiomyopathy, dilated, 1GG, (3); Leigh syndrome, (3), Autosomal, Mitochondrial; Mitochondrial respiratory chain complex II deficiency, (3), Autosomal ; Paragangliomas 5, (3), SGCD Cardiomyopathy, dilated, 1L, (3); Muscular dystrophy, limb-girdle, type 2F, (3), Autosomal SHOC Noonan-like syndrome with loose anagen hair, (3), Autosomal SLC25A Mitochondrial phosphate carrier deficiency, (3) SLMAP No OMIM phenotype SMAD Loeys-Dietz syndrome 3, (3), SNTA Long QT syndrome 12, (3), SOD {Microvascular complications of diabetes 6}, (3) SOS ?Fibromatosis, gingival, 1, (3), ; Noonan syndrome 4, (3), SPRED Legius syndrome, (3), SYNE Emery-Dreifuss muscular dystrophy 4, autosomal, (3), ; Spinocerebellar ataxia, autosomal 8, (3), Autosomal SYNE Emery-Dreifuss muscular dystrophy 5, autosomal, (3), TAZ Barth syndrome, (3), X-linked TBX Conotruncal anomaly face syndrome, (3); DiGeorge syndrome, (3), ; Tetralogy of Fallot, (3), ; Velocardiofacial syndrome, (3), Autosomal TBX Atrial septal defect 4, (3) TCAP Cardiomyopathy, hypertrophic, 25, (3), ; Muscular dystrophy, limb-girdle, type 2G, (3), Autosomal TGFB Loeys-Dietz syndrome 4, (3), TGFB Arrhythmogenic right ventricular dysplasia 1, (3), Autosomal ; Loeys-Dietz syndrome 5, (3), TGFBR TGFBR Loeys-Dietz syndrome 1, (3), ; {Multiple selfhealing squamous epithelioma, susceptibility to}, (3), Autosomal Colorectal cancer, hereditary nonpolyposis, type 6, (3); Esophageal cancer, somatic, (3); Loeys-Dietz syndrome 2, (3), TLL Atrial septal defect 6, (3), TMEM Arrhythmogenic right ventricular dysplasia 5, (3), Autosomal ; Emery-Dreifuss muscular dystrophy 7, AD, (3), 10/12
11 TMEM Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2, (3), Autosomal TMPO No OMIM phenotype TNNC Cardiomyopathy, dilated, 1Z, (3); Cardiomyopathy, hypertrophic, 13, (3), TNNI Cardiomyopathy, dilated, 1FF, (3);?Cardiomyopathy, dilated, 2A, (3), Autosomal ; Cardiomyopathy, familial restrictive, 1, (3), ; Cardiomyopathy, hypertrophic, 7, (3), TNNT TPM Cardiomyopathy, dilated, 1D, (3), ; Cardiomyopathy, familial restrictive, 3, (3), ; Cardiomyopathy, hypertrophic, 2, (3), ; Left ventricular noncompaction 6, (3), Cardiomyopathy, dilated, 1Y, (3), ; Cardiomyopathy, hypertrophic, 3, (3), ; Left ventricular noncompaction 9, (3), TRDN Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness, (3), Autosomal TRIM No OMIM phenotype TRPM Progressive familial heart block, type IB, (3), TSFM TTN TTR Combined oxidative phosphorylation deficiency 3, (3), Autosomal Cardiomyopathy, dilated, 1G, (3); Cardiomyopathy, familial hypertrophic, 9, (3), ; Muscular dystrophy, limb-girdle, type 2J, (3), Autosomal ; Myopathy, proximal, with early respiratory muscle involvement, (3); Salih myopathy, (3), Autosomal ; Tibial muscular dystrophy, tardive, (3), Amyloidosis, hereditary, transthyretin-related, (3), Autosomal ; Carpal tunnel syndrome, familial, (3), Autosomal ; [Dystransthyretinemic hyperthyroxinemia], (3), TXNRD No OMIM phenotype VCL Cardiomyopathy, dilated, 1W, (3); Cardiomyopathy, hypertrophic, 15, (3), XK ZFPM McLeod syndrome with or without chronic granulomatous disease, (3), X-linked Diaphragmatic hernia 3, (3); Tetralogy of Fallot, (3), ; 46XY sex reversal 9, (3), Autosomal 11/12
12 Gene symbols used are according to the HGNC guidelines. For some genes a previously HGNCapproved symbol is in brackets. Each Phenotype is followed by its MIM number, phenotype mapping key and inheritance pattern. OMIM release used for OMIM disease identifiers and descriptions: June 06, 2017 Possible phenotype mapping keys (1) the disorder is placed on the map based on its association with a gene, but the underlying defect is not known (2) the disorder has been placed on the map by linkage; no mutation has been found (3) the molecular basis for the disorder is known; a mutation has been found in the gene (4) a contiguous gene deletion or duplication syndrome, multiple genes are deleted or duplicated causing the phenotype Brackets, "[ ]", indicate "nondiseases," mainly genetic variations that lead to apparently abnormal laboratory test values (e.g., dysalbuminemic euthyroidal hyperthyroxinemia). Braces, "{ }", indicate mutations that contribute to susceptibility to multifactorial disorders (e.g., diabetes, asthma) or to susceptibility to infection (e.g., malaria). A question mark, "?", before the phenotype name indicates that the relationship between the phenotype and gene is provisional. More details about this relationship are provided in the comment field of the map and in the gene and phenotype OMIM entries. 12/12
Heterotaxie PCD (Primaire ciliaire dyskinesie) panel
Heterotaxie PCD (Primaire ciliaire dyskinesie) panel versie V1 (92 genen) Centrum voor Medische Genetica Gent Gene OMIM gene ID Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance
More informationCOMPLETE A FORM FOR EACH SAMPLE SUBMITTED ETHNIC BACKGROUND REPORTING INFORMATION
DATE SAMPLE DRAWN: SAMPLE TYPE: BLOOD OTHER (SPECIFY): COMPLETE A FORM FOR EACH SAMPLE SUBMITTED PATIENT FIRST NAME: LAST NAME: DOB: SEX: M F UNKNOWN ADDRESS: HOME PHONE: ( ) WORK: ( ) EUROPEAN CAUCASIAN
More informationPaediatric Cardiomyopathy
Paediatric Cardiomyopathy Contact details: Bristol Genetics Laboratory Pathology Sciences Southmead Hospital Bristol, BS10 5NB Enquiries: 0117 414 6174 FAX: 0117 414 6464 Head of department: Eileen Roberts
More informationNGS in Diagnostics: a practical example in hereditary cardiomyopathies
NGS in Diagnostics: a practical example in hereditary cardiomyopathies Patricia Norambuena University Hospital Motol, Prague. 2 nd Faculty of Medicine, Charles University VEP Course - November 6 th - 8th,
More informationTest Information Sheet
Combined Cardiac Panel Test Information Sheet Panel Gene List: ABCC9, ACTC1, ACTN2, AKAP9, ALMS1, ALPK3, ANK2, ANKRD1, BAG3, BRAF, CACNA1C, CACNA2D1, CACNB2, CALM1, CALM2, CALM3, CASQ2, CAV3, CHRM2, CRYAB,
More informationThe Genetics and Prevention of Sudden Cardiac Death
The Genetics and Prevention of Sudden Cardiac Death Sudden cardiac death (SCD), a serious public health problem Every day, between 1,600 and 2,000 people die worldwide from genetically caused SCD. 1 SCD
More informationInherited Arrhythmia Syndromes
Inherited Arrhythmia Syndromes When to perform Genetic testing? Arthur AM Wilde February 4, 2017 Which pts should undergo genetic testing? SCD victims with a likely diagnosis Pts diagnosed with an inherited
More informationHomozygous PKP2 deletion associated with neonatal left ventricle noncompaction
Clin Genet 2017: 91: 126 130 Printed in Singapore. All rights reserved Short Report 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd CLINICAL GENETICS doi: 10.1111/cge.12780 Homozygous PKP2
More informationMolecular Diagnostic Laboratory 18 Sequencing St, Gene Town, ZY Tel: Fax:
Molecular Diagnostic Laboratory 18 Sequencing St, Gene Town, ZY 01234 Tel: 555-920-3333 Fax: 555-920-3334 www.moldxlaboratory.com Patient Name: Jane Doe Specimen type: Blood, peripheral DOB: 04/05/1990
More informationGenetic testing in Cardiomyopathies
Genetic testing in Cardiomyopathies Silvia Giuliana Priori Cardiovascular Genetics, Langone Medical Center, New York University School of Medicine, New York, USA and Molecular Cardiology, IRCCS Fondazione
More informationcataract panel 16-Apr-2018 (63 genen) Centrum voor Medische Genetica Gent versie OMIM gene ID
versie 16-Apr-2018 (63 genen) cataract panel Centrum voor Medische Genetica Gent Gene OMIM gene ID AGK 610345 ALDH18A1 138250 Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance
More informationFamily stories: to illustrate inheritance and the impact on families. Dr Claire Turner Consultant clinical geneticist
Family stories: to illustrate inheritance and the impact on families Dr Claire Turner Consultant clinical geneticist Overview With respect to inherited cardiac conditions Simple modes of inheritance (Mendelian)
More informationPreventing Sudden Death in Young Athletes. Outline. Scope of the Problem. Causes of SCD in Young Athletes. Sudden death in the young athlete
Preventing Sudden Death in Young Athletes Ronn E. Tanel, MD Director, Pediatric Arrhythmia Service UCSF Children s Hospital Associate Professor of Pediatrics UCSF School of Medicine Outline Sudden death
More informationCilioPathy panel. 3-Jul-2018 (102 genen) Centrum voor Medische Genetica Gent. versie. OMIM gene ID
versie 3-Jul-2018 (102 genen) CilioPathy panel Centrum voor Medische Genetica Gent Gene OMIM gene ID Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance pattern AHI1 608894 Joubert
More informationMAC-ASD panel. 16-Apr-2018 (59 genen) Centrum voor Medische Genetica Gent. versie. OMIM gene ID
versie 16-Apr-2018 (59 genen) MAC-ASD panel Centrum voor Medische Genetica Gent Gene OMIM gene ID Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance pattern ABCB6 605452 [Blood
More informationMatters of the heart: genetic and molecular characterisation of cardiomyopathies Posafalvi, Anna
University of Groningen Matters of the heart: genetic and molecular characterisation of cardiomyopathies Posafalvi, Anna IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationClinical Genetics in Cardiomyopathies
Clinical Genetics in Cardiomyopathies Γεώργιος Κ Ευθυμιάδης Αναπληρωτής Καθηγητής Καρδιολογίας ΑΠΘ No conflict of interest Genetic terms Proband: The first individual diagnosed in a family Mutation: A
More informationSudden cardiac death: focus on the genetics of channelopathies and cardiomyopathies
Magi et al. Journal of Biomedical Science (2017) 24:56 DOI 10.1186/s12929-017-0364-6 REVIEW Sudden cardiac death: focus on the genetics of channelopathies and cardiomyopathies Simona Magi 1*, Vincenzo
More informationpanel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders
NGS tests panel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders UKGTN website lists 13 laboratories offering a total of 56 panel test UKGTN listed panel
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Estimation of false discovery rate To estimate the false discovery rate, we first estimated the rate of private non-synonymous mutations in all exons of all other genes, disregarding
More informationCorporate Medical Policy
Corporate Medical Policy Genetic Testing for Predisposition to Inherited Hypertrophic File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_predisposition_to_inherited_hypertrophic_cardiomyopathy
More informationHypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy From Genetics to ECHO Alexandra A Frogoudaki Second Cardiology Department ATTIKON University Hospital Athens University Athens, Greece EUROECHO 2010, Copenhagen, 11/12/2010
More informationMolecular Diagnosis of Genetic Diseases: From 1 Gene to 1000s
ROMA, 23 GIUGNO 2011 Molecular Diagnosis of Genetic Diseases: From 1 Gene to 1000s USSD Lab Genetica Medica Ospedali Riuniti Bergamo The problem What does the clinician/patient want to know?? Diagnosis,
More informationCardiac Considerations and Care in Children with Neuromuscular Disorders
Cardiac Considerations and Care in Children with Neuromuscular Disorders - importance of early and ongoing treatment, management and available able medications. Dr Bo Remenyi Department of Cardiology The
More informationDepartments of Pediatrics and Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis Indiana;
Evaluation of Genetic Causes of Cardiomyopathy in Childhood Stephanie M. Ware 1 * 1 Departments of Pediatrics and Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis Indiana;
More informationJ. Peter van Tintelen MD PhD Clinical Geneticist Amsterdam, the Netherlands
Inherited arrhythmia syndromes I: What you always wanted to know, but were afraid to ask: The basics of inherited arrhythmia syndromes and gene:cs J. Peter van Tintelen MD PhD Clinical Geneticist Amsterdam,
More informationInformed Consent Columbia Whole Genome or Whole Exome Sequencing
Informed Consent Columbia Whole Genome or Whole Exome Sequencing Please read the following form carefully and discuss with your ordering physician before signing consent. This consent is intended for the
More informationInherited Cardiomyopathies Molecular genetics and Clinical genetic testing
Inherited Cardiomyopathies Molecular genetics and Clinical genetic testing Dr Shagun Aggarwal Associate Professor, Department of Medical Genetics Nizam s Institute of Medical Sciences Adjunct Scientist,
More informationLES NOUVEAUX TROUBLES DE CONDUCTION HEREDITAIRES
LES NOUVEAUX TROUBLES DE CONDUCTION HEREDITAIRES Alban Baruteau L institut du thorax, INSERM 1087 CNRS 6291 IRS Université de Nantes Centre Chirurgical Marie Lannelongue M3C Université Paris Sud Le Kremlin
More informationHeart Development and Congenital Heart Disease
Heart Development and Congenital Heart Disease Sally Dunwoodie s.dunwoodie@victorchang.edu.au Developmental and Stem Cell Biology Division Victor Chang Cardiac Research Institute for the heart of Australia...
More informationCardiac arrest in a toddler treated with propranolol for infantile Hemangioma: a case report
Tosoni et al. Italian Journal of Pediatrics (2017) 43:103 DOI 10.1186/s13052-017-0421-5 CASE REPORT Open Access Cardiac arrest in a toddler treated with propranolol for infantile Hemangioma: a case report
More informationSUPPLEMENTAL MATERIAL ADDITIONAL TABLES
SUPPLEMENTAL MATERIAL ADDITIONAL TABLES Table S1. List of distinct rare variants detected by high-throughput sequencing in our cohort. The number of patients with each variant and the reference for the
More informationGenetics of Sudden Cardiac Death. Geoffrey Pitt Ion Channel Research Unit Duke University. Disclosures: Grant funding from Medtronic.
Genetics of Sudden Cardiac Death Geoffrey Pitt Ion Channel Research Unit Duke University Disclosures: Grant funding from Medtronic Duke U N I V E R S I T Y Sudden Cardiac Death High incidence 50-100 per
More informationCode CPT Descriptor Test Purpose and Method Crosswalk Recommendation SEPT9 (Septin9) (e.g., colorectal cancer) methylation analysis
ASSOCIATION FOR MOLECULAR PATHOLOGY Education. Innovation & Improved Patient Care. Advocacy. 9650 Rockville Pike. Bethesda, Maryland 20814 Tel: 301-634-7939 Fax: 301-634-7995 amp@amp.org www.amp.org August
More informationReview. The Genetics of Cardiac Disease Associated with Sudden Cardiac Death
ASIP 2012 JMD CME Program Review The Journal of Molecular Diagnostics, Vol. 14, No. 5, September 2012 Copyright 2012 American Society for Investigative Pathology and the Association for Molecular Pathology.
More informationSpieraandoeningen genpanel v2 (148 genen)
Spieraandoeningen genpanel v2 (148 genen) Gene ACADVL 99,8 VLCAD deficiency, 201475 ACTA1 99,1 Nemaline myopathy 3, autosomal dominant or recessive, 161800 Myopathy, actin, congenital, with excess of thin
More informationWhole Exome Sequencing (WES): Questions and Answers for Providers
Whole Exome Sequencing (WES): Questions and Answers for Providers 1. What is Whole Exome Sequencing?... 2 2. What is the difference between Whole Exome Sequencing (WES) and Whole Exome Sequencing Plus
More informationCardiomyopathy in Fabry s disease
Cardiomyopathy in Fabry s disease Herzinsuffizienzlunch Basel, 11.09.2018 Christiane Gruner Kardiologie, UniversitätsSpital Zürich Content Background / epidemiology Differential diagnosis Clinical presentations
More informationAortopathy Gene Testing by Sanger sequencing
Department of Molecular Genetics Aortopathy Gene Testing by Sanger sequencing Mutation screening for Marfan syndrome and related disorders has grown to include many genes with overlapping phenotypes. We
More informationFamilial DilatedCardiomyopathy Georgios K Efthimiadis, MD
Familial DilatedCardiomyopathy Georgios K Efthimiadis, MD Dilated Cardiomyopathy Dilated LV/RV, reduced EF, in the absence of CAD valvulopathy pericardial disease Prevalence:40/100.000 persons Natural
More informationCongenital Heart Defects
C H A P T E R 46 Congenital Heart Defects Rocio Moran Department of Pediatric Genetics, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA Nathaniel H Robin Department of Genetics and Pediatrics,
More informationGenetic Cardiomyopathies
2017 HFCT Annual Scientific Meeting The Heart Failure Crosstalk Genetic Cardiomyopathies Teerapat Yingchoncharoen M.D. Ramathibodi Hospital Cardiomyopathy Group of diseases of the myocardium associated
More informationGenetics of cardiomyopathy and channelopathy
Genetics of cardiomyopathy and channelopathy Heart Failure Research Center, Department of Experimental Cardiology, AMC, Amsterdam, The Netherlands Correspondence: C. R. Bezzina, Heart Failure Research
More informationHeart Failure Compendium. Thomas J. Cahill, Houman Ashrafian, Hugh Watkins
Heart Failure Compendium Circulation Research Compendium on Heart Failure Research Advances in Heart Failure: A Compendium Epidemiology of Heart Failure Genetic Cardiomyopathies Causing Heart Failure Non-coding
More informationCHRONIC MYELOGENOUS LEUKEMIA
CHRONIC MYELOGENOUS LEUKEMIA SHUFFLING THE GENETIC DECK IN CML 9 9 (q+) 22 Ph (22q-) bcr bcr-abl abl Fusion protein causes cancer GLEEVEC AND BCR-ABL FUSION PROTEIN GENETIC MEDICINE A. Genetic diseases
More informationPre-implantation genetic diagnosis (pgd) for heart disease determined by genetic factors
Interventional Cardiology Pre-implantation genetic diagnosis (pgd) for heart disease determined by genetic factors The application of PGD has currently been extended to an increasing number of common disorders
More informationSudden cardiac death: Primary and secondary prevention
Sudden cardiac death: Primary and secondary prevention By Kai Chi Chan Penultimate Year Medical Student St George s University of London at UNic Sheba Medical Centre Definition Sudden cardiac arrest (SCA)
More informationRhythm and Blues Drugs and QT Prolongation
Rhythm and Blues Drugs and QT Prolongation Dr Martin Quinn St Vincents University Hospital Irish Medication Safety Network conference Farmleigh 18 Oct 2013 Drugs and QT Prolongation Anti-psychotic, antidepressant,
More informationSudden cardiac death (SCD) accounts for 20% of mortality. Sudden Cardiac Death Compendium. Genetics of Sudden Cardiac Death
Sudden Cardiac Death Compendium Circulation Research Compendium on Sudden Cardiac Death The Spectrum of Epidemiology Underlying Sudden Cardiac Death Sudden Cardiac Death Risk Stratification Genetics of
More informationReproducibility with zebrafish models of human health and disease
Reproducibility with zebrafish models of human health and disease Monte Westerfield, University of Oregon, Eugene, USA Sponsored by the Office of the Director National Institutes of Health, the National
More informationHereditary Cardiovascular Conditions. genetic testing for undiagnosed diseases
Hereditary Cardiovascular Conditions genetic testing for undiagnosed diseases What is Hypertrophic Cardiomyopathy (HCM)? normal heart heart with hcm Extra or thick heart muscle Typically in the left ventricle
More informationPharmacogenomics of Drug-Induced Conditions
Pharmacogenomics of Drug-Induced Conditions Dan M. Roden, M.D. Professor of Medicine and Pharmacology Director, Oates Institute for Experimental Therapeutics Assistant Vice-Chancellor for Personalized
More informationWorld Database for Pediatric and Congenital Heart Surgery Appendix G: Alagille Syndrome (intrahepatic biliary duct agenesis) Apert Syndrome
World Database for Pediatric and Congenital Heart Surgery Appendix G: Syndromes Terms and Definitions Alagille Syndrome (intrahepatic biliary duct agenesis) Alagille-Watson syndrome, is an autosomal dominant
More informationWhole exome sequencing Gene package Hereditary Congenital Defects version 3.1,
Whole Exome Sequencing Gene package Hereditary Congenital Defects, version 3.1, 22 11 2017 Technical information DNA was enriched using Agilent SureSelect Clinical Research Exome V2 capture and paired
More informationDefinition and classification of the cardiomyopathies. Georgios K Efthimiadis Ass Prof of Cardiology
Definition and classification of the cardiomyopathies Georgios K Efthimiadis Ass Prof of Cardiology Historical Context WHO: 1980 classification "heart muscle diseases of unknown cause" WHO 1995 classification
More informationDisclosures. Genetic testing goes mainstream
Disclosures I am an employee and shareholder of Sonic Healthcare. Sonic Healthcare provides a variety of medical genetic assays. I do not receive any direct or indirect benefits from other companies. Choosing
More informationRare Disease Conditions Eligibility Criteria v1.5.1
Rare Disease Conditions Criteria v1.5.1 Document Record ID Key Work stream Rare Diseases Programme Director Mark Caulfield Status Final Document Owner Richard Scott Version 1.5.1 Document Author Andrew
More informationEPICARDIAL ABLATION IN GENETIC CARDIOMYOPATHIES: A NEW FRONTIER
EPICARDIAL ABLATION IN GENETIC CARDIOMYOPATHIES: A NEW FRONTIER C. Pappone, M. M. Monasky, G. Ciconte Arrhythmology and Electrophysiology Department, IRCCS Policlinico San Donato, San Donato Milanese,
More informationCardiology Abbreviations and Diagnosis
Cardiology Abbreviations and Diagnosis =Aortopathy Clinic, =UCHAMP Clinic, IA Clinic=Inherited Arrhythmia Clinic Abbreviation Diagnosis Provider/Specialty Ablation Aortic Aneurysm Aortic Dissection AI
More informationProposal form for the evaluation of a genetic test for NHS Service Gene Dossier
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name and description (please provide any alternative names you wish listed) (A)-Testing
More informationMEDICAL GENOMICS LABORATORY. Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG)
Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG) Ordering Information Acceptable specimen types: Blood (3-6ml EDTA; no time limitations associated with
More informationNo mutations were identified.
Hereditary Heart Health Test DOB: May 25, 1977 ID: 123456 Sex: Female Requisition #: 123456 ORDERING PHYSICIAN Dr. Jenny Jones Sample Medical Group 123 Main St. Sample, CA SPECIMEN Type: Saliva Barcode:
More informationReview Article. Genetic Evaluation, Familial Screening and Exercise. Introduction. Keywords
Genetic Evaluation, Familial Screening and Exercise Ricardo Stein, 1,2,3,4 Juan Pablo Trujillo, 5,6 Anderson Donelli da Silveira, 1,4 Arsonval Lamounier Júnior, 5,6 Lorenzo Monserrat Iglesias 5,6 Programa
More informationNeurofibromatosis type 1 and RASopathies
Neurofibromatosis type 1 and RASopathies Dawn Siegel, MD Medical College of Wisconsin American Academy of Dermatology San Diego, CA February 19 th, 2018 Neurofibromatosis Type 1 NF1- diagnostic criteria
More informationNeonatal Hypotonia. Encephalopathy acute No encephalopathy. Neurology Chapter of IAP
The floppy infant assumes a frog legged position. On ventral suspension, the baby can not maintain limb posture against gravity and assumes the position of a rag doll. Encephalopathy acute No encephalopathy
More informationStrength and weakness of genetic testing in clinical routine.
Strength and weakness of genetic testing in clinical routine. Silvia G Priori MD PhD Molecular Cardiology, IRCCS Fondazione Maugeri Pavia, Italy AND Leon Charney Division of Cardiology, Cardiovascular
More informationCongenital Heart Defects
Normal Heart Congenital Heart Defects 1. Patent Ductus Arteriosus The ductus arteriosus connects the main pulmonary artery to the aorta. In utero, it allows the blood leaving the right ventricle to bypass
More informationHigh Yield Associations Cardio for Step 1. Amanda Krauss, Adee Elhamdani
High Yield Associations Cardio for Step 1 Amanda Krauss, Adee Elhamdani EKGs Irregularly irregular with no p waves and inconsistent RR intervals High Yield new onset MC risk factors Regular PP intervals
More informationInferring the Mammalian Cardiogenic Gene Regulatory Network. Jason Bazil 10/18/13 Cardiac Physiome Workshop 2013
Inferring the Mammalian Cardiogenic Gene Regulatory Network Jason Bazil 1/18/13 Cardiac Physiome Workshop 213 Reverse Engineering Gene Regulatory Networks Two main questions need addressed: 1) What s connected
More informationRARE DISEASE ELIGIBILITY STATEMENTS 100,000 Genomes Project
RARE DISEASE ELIGIBILITY STATEMENTS 100,000 Genomes Project Version 1.4 20 th January 2016 The controlled copy of this document is maintained in the Genomics England internal document management system.
More informationCLINICAL INFORMATION SHEET
CLINICAL INFORMATION SHEET Marfan syndrome and related aortic aneurysm syndromes Patient information Name: First Name(s): Sex: M F Date of Birth (dd/mm/yyyy): / / Address: Referring Physician: Referring
More informationAid to the MRCP PACES Volume 1 - Stations 1, 3 and 5,
Aid to the MRCP PACES Volume 1 - Stations 1, 3 and 5, Ryder ISBN-13: 9780470655092 Table of Contents Preface Preface to the third edition Preface to the second edition Preface to the first edition Introduction
More informationCardiac Catheterization Cases Primary Cardiac Diagnoses Facility 12 month period from to PRIMARY DIAGNOSES (one per patient)
PRIMARY DIAGNOSES (one per patient) Septal Defects ASD (Atrial Septal Defect) PFO (Patent Foramen Ovale) ASD, Secundum ASD, Sinus venosus ASD, Coronary sinus ASD, Common atrium (single atrium) VSD (Ventricular
More informationDr Philippe Charron. ESC congress, Stockholm, 29 August 2010
Inherited cardiomyopathies and and channelopathies: who is at risk for sudden cardiac death? Does genetic profiling predict risk in individual patients? Dr Philippe Charron Centre de Référence pour les
More informationStatutory Approvals Committee minutes
Statutory Approvals Committee minutes Centre 0102 (Guys Hospital) Pre-implantation Genetic Diagnosis (PGD) application for Muscular Dystrophy, Congenital, LMNA-related, (MDCL) OMIM #613205 Thursday, 25
More informationStrand Neuromuscular Disorders Test: Genes & Test Selection
1 Strand Neuromuscular Disorders Test: Genes & Test Selection 2 Can the Strand Neuromuscular Disorders Test Be Offered for Prenatal Diagnosis? 3 Strand Neuromuscular Disorders Test: Genes & Test Selection
More informationGenetics of Atrial Fibrillation: does it help in treatment decisions?
Genetics of Atrial Fibrillation: does it help in treatment decisions? Atrial fibrillation Pathophysiology of atrial fibrillation (AF) Genetic loci identified for AF Role in therapy outcome ardiologie Molecular
More informationLeft ventricular non-compaction: the New Cardiomyopathy on the Block
Left ventricular non-compaction: the New Cardiomyopathy on the Block Aamir Jeewa MB BCh, FAAP, FRCPC Section Head, Cardiomyopathy & Heart Function Program The Hospital for Sick Children Assistant Professor
More informationDescription. Page: 1 of 31. Genetic Testing for Cardiac Ion Channelopathies. Last Review Status/Date: December 2015
Genetic Testing for Cardiac Ion Last Review Status/Date: December 2015 Genetic Testing for Cardiac Ion Description Page: 1 of 31 Genetic testing is available for patients suspected of having cardiac ion
More informationHA Convention 2010 Dr Liz YP Yuen Department of Chemical Pathology Prince of Wales Hospital
HA Convention 2010 Dr Liz YP Yuen Department of Chemical Pathology Prince of Wales Hospital 1 2 Sudden death an unexpected natural death within a short time period, generally 1 hour or less from the onset
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bagnall RD, Weintraub RG, Ingles J, et al. A prospective study
More informationAccount # Notes. Physician Name Physician Phone Fax. Diagnosis. CLIA #38D Q11 REQ page 1 of 5
Knight Diagnostic Laboratories Fax: (855) 535-1329 Email: KDLClientServices@ohsu.edu Shipping: 2525 SW 3rd Ave, Ste 350, Portland, OR 97201 Questions? (855) 535-1522 Molecular Genetics Test Requisition
More informationPediatric Echocardiography Examination Content Outline
Pediatric Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 Anatomy and Physiology Normal Anatomy and Physiology 10% 2 Abnormal Pathology and Pathophysiology
More informationPearls of the ESC/ERS Guidelines 2015 Channelopathies
Pearls of the ESC/ERS Guidelines 2015 Channelopathies Carina Blomstrom Lundqvist Dept Cardiology, Uppsala, Sweden Content 2015 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias
More informationSEMINAIRES IRIS. Sudden cardiac death in the adult. Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel. 20% 25% Cancers !
Sudden cardiac death in the adult Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel.! " # $ % Cancers National Vital Statistics Report, Vol 49 (11), Oct. 12, 2001. 20% 25% State-specific
More informationA rare case of muscular dystrophy with POMT2 and FKRP gene mutation. Present by : Ghasem Khazaei Supervisor :Dr Mina Mohammadi Sarband
A rare case of muscular dystrophy with POMT2 and FKRP gene mutation Present by : Ghasem Khazaei Supervisor :Dr Mina Mohammadi Sarband Index : Congenital muscular dystrophy (CMD) Dystroglycanopathies Walker-Warburg
More informationHeart and Lungs. LUNG Coronal section demonstrates relationship of pulmonary parenchyma to heart and chest wall.
Heart and Lungs Normal Sonographic Anatomy THORAX Axial and coronal sections demonstrate integrity of thorax, fetal breathing movements, and overall size and shape. LUNG Coronal section demonstrates relationship
More informationPATIENT INFORMATION (Please Print or Place ID Label) Last Name First Name MI
Cytogenetics and Molecular Genetics Postnatal Genetic Test Requisition Form Laboratory Services Cytogenetics and Molecular Genetics Laboratory Tel: (614) 722-5321 / Fax: (614) 722-5471 PATIENT INFORMATION
More informationEthical Challenges of Genome-based Cancer Research: Return of individual research results
Ethical Challenges of Genome-based Cancer Research: Return of individual research results Gail P. Jarvik, M.D., Ph.D. Arno G. Motulsky Endowed Chair Medicine and Genome Sciences Head, Medical Genetics
More informationImplementation of routine predictive genetic testing for cardiovascular disease.
Implementation of routine predictive genetic testing for cardiovascular disease. 1 Implementation of routine predictive genetic testing for cardiovascular disease. Clinical application and ethical aspects.
More informationDear Parent/Guardian,
Dear Parent/Guardian, You have indicated on school records that your child has an ongoing health problem that may require medication and/or treatment during the school day with rescue medication. Attached
More informationCorporate Medical Policy
Corporate Medical Policy Genetic Testing for Marfan Syndrome, Thoracic Aortic Aneurysms and File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_marfan_syndrome_thoracic_aortic_aneurysms_and_dissections_and_relat
More informationKNOWING YOUR FAMILY HEALTH HISTORY COULD SAVE YOUR LIFE!
KNOWING YOUR FAMILY HEALTH HISTORY COULD SAVE YOUR LIFE! Why is my family health history so important? Several important reasons to know your family health history! Because some conditions run in families
More informationNeurogenetics Genetic Testing and Ethical Issues
Neurogenetics Genetic Testing and Ethical Issues Grace Yoon, MD, FRCP(C) Divisions of Neurology and Clinical and Metabolic Genetics The Hospital for Sick Children Objectives 1) To recognize the ethical
More informationGenetic Testing for Neurologic Disorders
Genetic Testing for Neurologic Disorders MP9497 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes as shown below Pre- and post-test genetic counseling
More informationCMS Limitations Guide - Radiology Services
CMS Limitations Guide - Radiology Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations
More informationEnormous progress has recently been made in identifying
Advances in Heart Failure Progress With Genetic Cardiomyopathies Screening, Counseling, and Testing in Dilated, Hypertrophic, and Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Ray E. Hershberger,
More informationUnexplained Sudden Cardiac Death in Saudi Arabia. Klinische Genetica
Unexplained Sudden Cardiac Death in Saudi Arabia Sudden Unexplained Death Boy: 1 year Girl: 1 and ½ year Girl: 16 year Boy: 26 year Boy: 16 year Family A and B: Referred by Dr. Tarek Momenah, PSCC Family
More informationFamilial Arteriopathies
Familial Arteriopathies Reed E. Pyeritz, MD, PhD Perelman School of Medicine University of Pennsylvania Longest and largest blood vessel Anatomical segments differ in physiologic function, embryonic origins
More information